Trial Profile
Evaluation of the Safety and Effectiveness of BELKYRA Inj. for the Treatment of Patients With Submental Fullness Due to Submental Fat: A Post Marketing Surveillance Study in Korea
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2020
Price :
$35
*
At a glance
- Drugs Deoxycholic acid (Primary)
- Indications Subcutaneous fat disorders
- Focus Therapeutic Use
- Sponsors AbbVie; Allergan
- 03 Dec 2020 Status changed from recruiting to discontinued.
- 08 Oct 2018 New trial record